Dr. Martens
British footwear brand known for durable air-cushioned boots, yellow welt stitching, and its association with music and youth subcultures.
Last updated August 31, 2026
Overview
Dr. Martens is a British footwear brand whose identity combines industrial durability with cultural self-expression. Its signature construction originated with German physician Klaus Märtens, who developed an air-cushioned sole after injuring his foot during a skiing holiday in 1945. Together with his university friend Herbert Funck, he began producing the design in Germany in 1947. The comfortable sole attracted an initial customer base dominated by older women, but the technology later found a commercial route into Britain when Northamptonshire footwear manufacturer R. Griggs Group acquired the British rights in the late 1950s. The first British Dr. Martens boot, the 1460, was introduced on 1 April 1960. Its eight-eyelet shape, smooth leather upper, grooved sides, distinctive yellow welt stitching, and air-cushioned sole created a recognizable product language. The boot began as practical work footwear, but its meaning changed as it was adopted by workers, musicians, young people, and subcultures. The Who’s Pete Townshend helped establish the boot as a symbol of working-class identity and nonconformity, while punk, ska, goth, alternative, and later fashion communities made the footwear part of their visual vocabulary. The brand expanded internationally through subsidiaries, distributors, stores, wholesale relationships, franchises, and digital commerce. It established operations in the United States, Italy, Germany, France, Japan, and China at different stages between the 1980s and 2000s. During the 1990s and early 2000s, changing consumer preferences and weaker performance in the United States created pressure. Most British manufacturing was closed in 2003, with production shifting largely to China and Thailand, although the company retained a Made in England range and subsequently strengthened its premium and heritage positioning. A later recovery was built around direct-to-consumer retail, e-commerce, international expansion, product diversification, and renewed emphasis on the brand’s cultural history. New categories included Chelsea boots, loafers, sandals, sneakers, platform styles, apparel, and accessories, while the 1460 and 1461 remained central icons. The 2014 acquisition by Permira accelerated investment in digital channels, stores, operations, and global brand management. Dr. Martens plc subsequently listed on the London Stock Exchange in February 2021. The brand’s commercial scope now spans classic footwear, seasonal fashion collections, collaborations, repair and care products, and limited editions. Its positioning rests on durability, recognizable design, longevity, and the idea that customers can personalize the products through styling and wear. Campaigns such as Tough As You, Made Strong, Pride Generations, and The Yellow Stitch have connected the brand with resilience, identity, inclusion, and contemporary creativity. Dr. Martens continues to operate internationally, with the United Kingdom as its historical base and Japan among its important Asian markets.
History
The technical foundation of Dr. Martens footwear was created by German physician Klaus Märtens after a foot injury in 1945. Seeking a more comfortable alternative to rigid conventional soles, Märtens designed an air-cushioned construction. In 1947 he and Herbert Funck began producing shoes in Germany, initially using reclaimed rubber materials. The comfort and durability of the design generated early demand, particularly among women over forty. The route to the modern brand began when R. Griggs Group, a Northamptonshire footwear manufacturer, acquired rights to produce the sole and associated design in Britain in the late 1950s. Griggs modified the construction, registered the AirWair name, and created the visual details that became strongly associated with the product, including yellow welt stitching and grooved sole edges. The 1460 eight-eye boot was launched in Britain on 1 April 1960, and the 1461 three-eye shoe followed in 1961. Although initially marketed as practical footwear for workers, the boots acquired cultural meaning during the 1960s and 1970s. The Who’s Pete Townshend wore them on stage, helping link the brand with music and working-class identity. Subsequent adoption by punk, ska, skinhead, goth, alternative, and other youth communities made Dr. Martens a visible symbol of independence and resistance. The products remained functional, but their significance increasingly depended on how different communities styled and interpreted them. International expansion followed. The company established or developed operations in the United States, Italy, Germany, France, Japan, and China over several decades. Japan became an important market, with a local corporate presence established in 1998. The brand also expanded beyond the original work boot into shoes, Chelsea boots, loafers, sandals, sneakers, platform designs, apparel, and accessories. The 1990s and early 2000s were difficult. Demand weakened in the United States, and most British production was closed in 2003, with manufacturing moving mainly to China and Thailand. The company retained a smaller Made in England operation, which later became important to its premium and heritage proposition. The business gradually rebuilt momentum by emphasizing fashion relevance, product variety, collaborations, direct retail, e-commerce, and the continuing cultural power of its classic silhouettes. R. Griggs Group was acquired by Permira-backed funds in 2013 or 2014, with reported coverage identifying the transaction value as £300 million. Under Permira, the business shifted from a predominantly wholesale manufacturing model toward a digitally led, consumer-focused, multichannel operation. Investment went into owned stores, the website, international infrastructure, supply-chain coordination, and brand storytelling. The company became Dr. Martens plc and floated on the London Stock Exchange in February 2021. During the 2020s, the company continued to use its icons as a platform for new materials, soles, colors, collaborations, and campaigns. Its communications increasingly addressed identity, inclusion, resilience, and community, while management also discussed bio-based materials, product longevity, repair, and potential second-life channels. Leadership changed from Kenny Wilson to Ije Nwokorie in January 2025, followed by further organizational efforts described as consumer-centered and product-led.
- 2025Chief executive succession
Ije Nwokorie became chief executive officer, succeeding Kenny Wilson.
- 2021London Stock Exchange listing
Dr. Martens plc listed on the London Stock Exchange under DOCS.
- 2014Permira acquisition
Permira-backed funds acquired the business from the Griggs family group.
- 2003Most British factories close
Most United Kingdom production was closed and manufacturing shifted mainly to Asian facilities, while a Made in England range remained.
- 19611461 shoe introduced
The three-eyelet 1461 became the brand’s second enduring core silhouette.
- 19601460 boot launched in Britain
R. Griggs introduced the first British Dr. Martens boot, later known as the 1460.
- 1947German production begins
Märtens and Herbert Funck began producing the footwear design in Germany.
- 1945Air-cushioned sole concept developed
Klaus Märtens designed a softer, air-cushioned sole after injuring his foot while skiing.
Products and positioning
Heritage footwear combining durability, air-cushioned comfort, recognizable design, and cultural self-expression.
1460Eight-eye boot1960
The 1460 is Dr. Martens’ defining eight-eye boot. Introduced in 1960, it combines a rounded toe, leather upper, pull tab, yellow welt stitching, grooved sole edge, and air-cushioned outsole. It began as workwear but became a cross-generational cultural icon through music, youth subcultures, and fashion. The style is offered in numerous leathers, colors, finishes, soles, and collaboration editions.
1461Three-eye shoe1961
The 1461 is the brand’s classic three-eyelet shoe, introduced in 1961. Its lower profile makes it suitable for workwear, schoolwear, formal-casual styling, and contemporary streetwear. Like the 1460, it is identified by the AirWair sole construction and yellow stitching, while seasonal materials and collaborations broaden its audience.
2976Chelsea boot
The 2976 is Dr. Martens’ interpretation of the Chelsea boot, using elastic side panels and a pull tab with the brand’s characteristic sole construction. It translates the brand’s rugged visual identity into a comparatively streamlined ankle boot and is regularly presented in core, platform, and seasonal versions.
JadonPlatform boot
Jadon builds on the 1460’s eight-eye boot profile with a raised platform or Quad sole. The taller silhouette gives the product a more pronounced fashion presence while retaining the brand’s recognizable stitching and construction details. It has become one of Dr. Martens’ important contemporary icons.
Made in EnglandPremium footwear range
Made in England is the brand’s premium heritage range, produced in the United Kingdom and associated with traditional construction, specialist craftsmanship, and classic silhouettes. It preserves a connection to Dr. Martens’ Northamptonshire manufacturing history while sitting alongside the company’s larger international production network.
Flagship businesses
- 1460 eight-eye boot
- 1461 three-eye shoe
- 2976 Chelsea boot
- Jadon platform boot
- Made in England footwear
Marketing campaigns
- 2025The Yellow Stitch
Japan
The holiday campaign centered on the 1460, 1461, and Jadon as examples of classic designs continually updated for new generations. Actor Sho Kasamatsu appeared in campaign materials, and a related live event was announced in Tokyo.
Outcome. Connected the yellow stitch signature and core products with holiday gifting, music, and Japanese cultural visibility.
- 2023Made Strong
Global · Japan
Made Strong focused on strength, flexibility, optimism, and the ways a new generation shapes its world. Events were planned in three cities including Tokyo, and Tokyo campaign imagery featured 11 people from varied creative fields wearing contemporary Dr. Martens styles.
Outcome. Reframed the heritage proposition for contemporary self-expression and community events.
- 2022Pride Generations
Global
A platform and video-led campaign amplified voices from LGBTQIA+ communities and addressed the brand’s historical relationship with queer culture, identity, and self-expression.
Outcome. Positioned the brand as a supporter of LGBTQIA+ storytelling during Pride-related communications.
- 20211461 Power
Japan
An Instagram campaign invited customers to share stories about confidence, individuality, and taking a step forward while wearing the 1461. Ten selected participants were offered new-season 1461 footwear.
Outcome. Generated user participation around the 1461 and the idea of personal empowerment.
- 20212976 Power
Japan
A Japan-focused Instagram campaign asked customers to share their experiences with the 2976 under the brand’s Power theme. The campaign also featured NANA MOMOSAKA and KAZANE discussing their relationships with the style.
Outcome. Extended the user-generated storytelling format from the 1461 to the 2976 Chelsea boot.
- 2019Tough As You
Global · United Kingdom · Japan
The campaign profiled artists and creators who had confronted personal or social barriers. It framed toughness as resilience and self-belief rather than merely physical durability, and featured Blaine Harrison, Nakhane Toure, Sarah Lu, and Sistren.
Outcome. Used documentary-style storytelling and portrait photography to connect the product heritage with personal resistance and inclusion.
Brand decisions
- 2025Move toward a consumer-centered operating modelStrategy
Management described a need to simplify the business and strengthen product-led marketing after weaker regional trading.
What changed. The company reorganized senior management around finance, brand, operations, commercial activity, technology, customer experience, and sustainability.
Aftermath. Ije Nwokorie’s leadership began a new phase focused on consumers, product, retail execution, and operating discipline.
- 2021Initial public offeringM&A
After several years of growth under Permira, the company sought a public-market listing.
What changed. Dr. Martens plc listed on the London Stock Exchange premium market under DOCS.
Aftermath. The listing gave the company a public-company structure while Permira retained a substantial shareholding at the time of the offering.
IPO opening price versus offer price. £3.70 offer price → £4.54 opening price (February 2021)
- 2014Permira acquisitionM&A
R. Griggs Group and its brand were acquired during a period when the business was being repositioned for renewed international growth.
What changed. Permira-backed funds acquired the company for a reported £300 million.
Aftermath. The business invested in direct-to-consumer retail, e-commerce, stores, operations, and global brand management.
Acquisition value. £300 million (2014)
- 2003Shift production away from most British factoriesStrategy
Weakening demand and changing market conditions placed pressure on the traditional manufacturing footprint.
What changed. Most British factories were closed and production moved mainly to China and Thailand, while a smaller Made in England operation continued.
Aftermath. The company retained a British-made premium proposition while operating a broader international manufacturing network.
Leadership
| Name | Title | Tenure |
|---|---|---|
| Ije Nwokorie | Chief Executive Officer | 2025– |
| Kenny Wilson | Chief Executive Officerformer | 2018–2025 |
| Darren McKoy | Creative Directorformer | 2015–2025 |
| Paul Mason | Chairman and interim Chief Executive Officerformer | — |
| Steve Murray | Chief Executive Officerformer | — |
Recent events
- 2025Ije Nwokorie appointed chief executive officer
Chief Brand Officer Ije Nwokorie succeeded Kenny Wilson as chief executive officer in an internal succession.
Leadership change - 2025Creative director Darren McKoy departs
Darren McKoy left the creative director role after approximately a decade with the brand; a successor was not immediately announced.
Leadership change - 2024First-half sales declined and the company reported an adjusted operating loss
Reported coverage described weaker first-half trading across regions and a transition toward product-led marketing, stronger United States retail, lower operating costs, and improved finances.
Other - 2021Dr. Martens lists on the London Stock Exchange
Dr. Martens plc completed its initial public offering on the London Stock Exchange’s premium market under the ticker DOCS.
M&AOther
Sources
- Dr. Martens Japanese Wikipedia article
- Dr. Martens Japan company profile
- Dr. Martens lists on the London Stock Exchange
- Dr. Martens CEO succession and first-half results
- Tough As You campaign
- Made Strong campaign
- Pride Generations campaign
- 1461 shoe introduced
- Permira acquisition
- 2976 Power
- The Yellow Stitch
- Move toward a consumer-centered operating model
- Creative director Darren McKoy departs
Cite this profile: Cite the canonical profile. /brand-wiki/ドクターマーチン · Editorial policy · How profiles are compiled